Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:
- Contract Manufacturing
- Product & Process Development
- Consulting
- GTP Services
- National Distribution
Progenitor Cell Therapy's History
Andrew L. Pecora, M.D. and Robert A. Preti, Ph.D. founded Progenitor Cell Therapy, LLC (PCT), in 1997 as a New Jersey limited liability company.
On March 1, 1999 PCT acquired the hematopoietic progenitor cell and tissue processing laboratory from Hackensack University Medical Center (HUMC), located in Hackensack, New Jersey. At the time of the acquisition, Dr. Preti was HUMC's Scientific and Laboratory Director.
PCT began its current business operations, which included providing stem cell and tissue processing services for cancer patients under treatment at HUMC and other hospitals throughout the United States.
Subsequent to its acquisition by PCT, the laboratory was upgraded to a custom-built, 2,500 square foot, state-of-the-art manufacturing facility in a new building within the HUMC hospital complex. The laboratory has since been developed into a nationally recognized center for stem cell engineering.
The laboratory is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), and its operations are based upon quality systems, as described in Title 21 CFR compliance with cGMP and cGTP guidelines promulgated by the FDA.
